The Biotech Growth Trust (BIOG)

Business description

The Biotech Growth Trust seeks capital appreciation through investing in the worldwide biotechnology industry, mainly in emerging biotechnology companies. Performance is measured against its benchmark index, the NASDAQ Biotechnology Index (sterling adjusted).

Stock data

Market cap.£445m
Last close797.00p
High / Low (52 weeks)822.5p / 627.8p
Stock market listingLN
Forecast net debt (m)N/A
Forecast gearing ratio (%)N/A
TeamInvestment Companies
SectorInvestment Companies

Other companies in sector Show

Aberdeen New Dawn Investment Trust Aberdeen New Thai Investment Trust
Aberdeen Private Equity Fund Aberdeen UK Tracker Trust
AcenciA Debt Strategies Acorn Income Fund
Alliance Trust Altamir SCA
Amphion Innovations Aurelius
Bailador Tech Investments Bankers Investment Trust (The)
BB Biotech BlackRock Greater Europe Investment Trust
BlackRock Hedge Selector BlackRock Latin American Inv. Trust
British Portfolio Trust Brunner Investment Trust (The)
Canadian General Investments Carador Income Fund
Charles Stanley Circle Property
City Natural Resources Conversus Capital
CQS Rig Finance Fund CVC Credit Partners European Opps
Detour Gold Deutsche Beteiligungs
Dexion Commodities Diverse Income Trust (The)
DouglasBay Capital Dunedin Enterprise Investment Trust
DW Catalyst Fund Edinburgh Worldwide Investment Trust (The)
European Assets Trust European Investment Trust Plc (The)
F&C Managed Portfolio Growth F&C US Smaller Companies
Fidelity China Special Situations Fidelity European Values
Finsbury Growth & Income Trust Foreign & Colonial Investment Trust
Gartmore Growth Opportunities Gartmore Irish Growth Fund
Geiger Counter Limited GLI Alternative Finance
Global Resources Investment Trust Golden Prospect Precious Metals
Hansa Trust (HAN) HarbourVest Global Private Equity
HarbourVest Senior Loans Europe HBM Healthcare Investments
Heliad Equity Partners Henderson Alternative Strategies Trust
Henderson Far East Income Henderson Global Trust
Henderson Global Trust Henderson International Income Trust
HSBC Infrastructure Company Infrastructure India
International Biotechnology Trust Invesco Asia Trust
Invesco Income Growth Trust Is Private Equity
JP Morgan Private Equity Limited JPMorgan Brazil Investment Trust
JPMorgan European Smaller Companies Trust JPMorgan Global Convertibles Income Fund
JPMorgan Global Growth & Income JPMorgan Indian Investment Trust
Jupiter Green Investment Trust Jupiter UK Growth Investment Trust
Jupiter US Smaller Companies JZ Capital Partners Limited
Lazard World Trust Fund Leaf Clean Energy Company
LMS Capital Lowland Investment Company
LPEQ Martin Currie Asia Unconstrained Trust
Martin Currie Global Portfolio Trust Middlefield Canadian Income
Miton Global Opportunities Miton Income Opportunities Trust
New City Energy Ocean Wilsons Holdings
Pacific Assets Trust Phaunos Timber Fund
Polar Capital Global Healthcare Trust PXP Vietnam Fund
Qatar Investment Fund Rathbone Brothers
RENN Universal Growth Investment Trust Schroder AsiaPacific Fund
Schroder Global Real Estate Securities ScotGems
Scottish Oriental Smaller Companies Securities Trust of Scotland
Seneca Global Income & Growth Trust Sigma Capital Group
Standard Life Equity Income Trust Standard Life Investments Property Income Trust
Standard Life Pvt. Equity Trust Standard Life UK Smaller Companies
Strategic Equity Capital Taiwan Fund (The)
Templeton Emerging Markets Investment Trust Tetragon Financial Group
The Law Debenture Corporation The Merchants Trust
The North American Income Trust The Scottish Investment Trust
Tiso Blackstar Group TR European Growth trust
UK Commercial Property Trust Utilico Emerging Markets
Vietnam Enterprise Investments Vietnam Holding Asset Management
Vietnam Infrastructure Fund VinaCapital Vietnam Opportunity Fund
VinaLand Vision Opportunity China Fund
WAM Active WAM Capital
WAM Research Witan Investment Trust
Witan Pacific Investment Trust Worldwide Healthcare Trust
YFM Equity Partners

Company news

£10000 into £31000 in three years: can this fund keep rising?

Wed, 24 Sep 2014 10:43:47 GMT

Are biotech funds set to bounce back over the rest of 2016?

Thu, 16 Jun 2016 11:11:14 GMT

The Diary of a Private Investor: Biotech stands accused of being a bubble but ...

Thu, 16 Apr 2015 16:52:30 GMT

Investment Trust Watch: Murray International going cheap

Fri, 17 Jul 2015 12:14:11 GMT

Investment Trust Watch: biotech boom throws up 'bargains'

Thu, 22 Jun 2017 13:13:17 GMT

Investment summary

The Biotech Growth Trust (BIOG) was launched in 1997, aiming to generate long-term capital growth from a global portfolio of biotech stocks. Since 2005, the trust has been managed by OrbiMed Capital, the largest global specialist healthcare investor; over this period, BIOG has significantly outperformed its benchmark NASDAQ Biotech Index (sterling adjusted), despite less compelling short-term performance. The trust’s managers are bullish on the outlook for the biotech industry due to continued innovation, and suggest that investor concerns about drug price controls are overdone and have led to attractive biotech company valuations, especially for the larger-cap stocks. They believe that greater clarity surrounding US tax policy, including the potential repatriation of overseas cash, could lead to more industry mergers and acquisitions (M&A), which should be an important driver for the sector and could lead to a positive revaluation of the industry.

Last updated on 25/07/2017

Key management

Andrew Joy, Chairman
Richard Klemm, Fund manager
Geoffrey Hsu, Fund manager

Company address

One Wood Street
London
EC2V 7WS
United Kingdom
View website